Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor einem Tag · 01.07.2024 - BOSTON, July 01, 2024 (GLOBE NEWSWIRE) - Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course ...

  2. Vor 6 Stunden · Lifestyle. Horoscopes – July 2024. CANCER. 21 June – 22 July. You will benefit from a special talent, enthusiasm or passion which you could turn into income, or extra prestige. Work is a scurry of activity, and this period also favours stepping up physical activity or health routines. The end result is a newfound identity and a realistic ...

  3. Vor 6 Stunden · Verve Therapeutics, Inc, a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for ...

  4. Vor 6 Stunden · Verve Therapeutics had a negative return on equity of 37.35% and a negative net margin of 1,226.51%. Verve Therapeutics’s revenue for the quarter was up 305.6% on a year-over-year basis. Sell ...

  5. Vor 6 Stunden · VERVE offers a free consult for every procedure to ensure you are have all the information when choosing the right cosmetic procedure from an expert you can trust for full facial rejuvenation and eye bag elimination, Verve Medical Cosmetics offers the most focused non-surgical solutions.

  6. Vor 6 Stunden · Ed Conway makes those distant achievements fresh again with scholarship and verve. This is living history: and a seam worth mining further. Next, perhaps, he might try the birth of the euro, with smelling salts as well as cognac unlimited?

  7. Vor 6 Stunden · Verve Therapeutics stock opened at $4.98 on Tuesday. The stock has a fifty day moving average price of $5.64 and a two-hundred day moving average price of $10.07. Verve Therapeutics has a 52-week ...